|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Acumen Pharmaceuticals, Inc. (ABOS) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
60,080,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$ - $ |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Acumen Pharmaceuticals discovers and develops targeted therapies for the treatment of Alzheimer's disease. Co.'s primary drug candidate, ACU193, is a humanized monoclonal antibody which selectively targets amyloid-beta oligomers. Co. holds exclusive rights to the program.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
206,044 |
206,044 |
261,480 |
352,110 |
| Total Sell Value |
$390,329 |
$390,329 |
$482,295 |
$649,313 |
| Total People Sold |
7 |
7 |
7 |
7 |
| Total Sell Transactions |
25 |
25 |
31 |
36 |
| End Date |
2025-10-23 |
2025-07-22 |
2025-01-21 |
2024-01-22 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Oconnell Daniel Joseph |
Chief Executive Officer |
• • – |
2026-01-20 |
4 |
A |
$0.00 |
$0 |
D/D |
299,800 |
893,310 |
|
- |
|
| Doherty James J. |
President and CDO |
• – – |
2026-01-16 |
4 |
A |
$0.00 |
$0 |
D/D |
166,867 |
220,900 |
|
- |
|
| Meisner Derek M |
Chief Legal Officer & Corp Sec |
• – – |
2026-01-16 |
4 |
A |
$0.00 |
$0 |
D/D |
99,133 |
182,933 |
|
- |
|
| Siemers Eric |
Chief Medical Officer |
• – – |
2026-01-16 |
4 |
A |
$0.00 |
$0 |
D/D |
99,133 |
258,597 |
|
- |
|
| Barton Russell |
Chief Operating Officer |
• – – |
2026-01-16 |
4 |
A |
$0.00 |
$0 |
D/D |
84,600 |
207,869 |
|
- |
|
| Schacterle Amy |
Chief Regulatory Officer |
• – – |
2026-01-16 |
4 |
A |
$0.00 |
$0 |
D/D |
84,600 |
92,303 |
|
- |
|
| Zuga Matt |
CFO & Chief Business Officer |
• – – |
2026-01-16 |
4 |
A |
$0.00 |
$0 |
D/D |
99,133 |
309,084 |
|
- |
|
| Oconnell Daniel Joseph |
Chief Executive Officer |
• • – |
2026-01-12 |
4 |
AS |
$1.73 |
$9,307 |
D/D |
(5,388) |
593,510 |
|
- |
|
| Meisner Derek M |
Chief Legal Officer & Corp Sec |
• – – |
2026-01-12 |
4 |
AS |
$1.71 |
$14,658 |
D/D |
(8,548) |
83,800 |
|
- |
|
| Oconnell Daniel Joseph |
Chief Executive Officer |
• • – |
2026-01-09 |
4 |
AS |
$1.76 |
$22,832 |
D/D |
(12,941) |
598,898 |
|
- |
|
| Meisner Derek M |
Chief Legal Officer & Corp Sec |
• – – |
2026-01-09 |
4 |
AS |
$1.76 |
$9,169 |
D/D |
(5,200) |
92,348 |
|
- |
|
| Oconnell Daniel Joseph |
Chief Executive Officer |
• • – |
2026-01-08 |
4 |
AS |
$1.82 |
$14,815 |
D/D |
(8,143) |
611,839 |
|
- |
|
| Barton Russell |
Chief Operating Officer |
• – – |
2026-01-08 |
4 |
AS |
$1.86 |
$6,562 |
D/D |
(3,530) |
123,269 |
|
- |
|
| Meisner Derek M |
Chief Legal Officer & Corp Sec |
• – – |
2026-01-08 |
4 |
AS |
$1.82 |
$67,246 |
D/D |
(36,911) |
97,548 |
|
- |
|
| Zuga Matt |
CFO & Chief Business Officer |
• – – |
2026-01-08 |
4 |
AS |
$1.82 |
$12,513 |
D/D |
(6,888) |
209,951 |
|
- |
|
| Doherty James J. |
President and CDO |
• – – |
2026-01-08 |
4 |
AS |
$1.82 |
$11,769 |
D/D |
(6,467) |
54,033 |
|
- |
|
| Doherty James J. |
President and CDO |
• – – |
2026-01-07 |
4 |
AS |
$1.99 |
$3,379 |
D/D |
(1,700) |
60,500 |
|
- |
|
| Schacterle Amy |
Chief Regulatory Officer |
• – – |
2026-01-07 |
4 |
AS |
$1.98 |
$2,176 |
D/D |
(1,097) |
7,703 |
|
- |
|
| Meisner Derek M |
Chief Legal Officer & Corp Sec |
• – – |
2026-01-07 |
4 |
AS |
$1.99 |
$23,414 |
D/D |
(11,770) |
134,459 |
|
- |
|
| Zuga Matt |
CFO & Chief Business Officer |
• – – |
2026-01-07 |
4 |
AS |
$1.99 |
$11,566 |
D/D |
(5,805) |
216,839 |
|
- |
|
| Barton Russell |
Chief Operating Officer |
• – – |
2026-01-07 |
4 |
AS |
$1.99 |
$3,378 |
D/D |
(1,700) |
126,799 |
|
- |
|
| Oconnell Daniel Joseph |
Chief Executive Officer |
• • – |
2026-01-07 |
4 |
AS |
$1.99 |
$74,981 |
D/D |
(37,755) |
619,982 |
|
- |
|
| Meisner Derek M |
Chief Legal Officer & Corp Sec |
• – – |
2026-01-06 |
4 |
AS |
$1.97 |
$21,438 |
D/D |
(10,898) |
146,229 |
|
- |
|
| Siemers Eric |
Chief Medical Officer |
• – – |
2026-01-06 |
4 |
AS |
$1.97 |
$13,442 |
D/D |
(6,834) |
159,464 |
|
- |
|
| Zuga Matt |
CFO & Chief Business Officer |
• – – |
2026-01-06 |
4 |
AS |
$1.97 |
$10,028 |
D/D |
(5,100) |
222,644 |
|
- |
|
94 Records found
|
|
Page 1 of 4 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
